nodes	percent_of_prediction	percent_of_DWPC	metapath
Tiagabine—SLC6A1—epilepsy syndrome	0.152	1	CbGaD
Tiagabine—SLC6A1—Clobazam—epilepsy syndrome	0.145	0.85	CbGbCtD
Tiagabine—Decreased Central Nervous System Disorganized Electrical Activity—Fosphenytoin—epilepsy syndrome	0.0352	0.0875	CiPCiCtD
Tiagabine—Decreased Central Nervous System Disorganized Electrical Activity—Felbamate—epilepsy syndrome	0.0352	0.0875	CiPCiCtD
Tiagabine—Decreased Central Nervous System Disorganized Electrical Activity—Levetiracetam—epilepsy syndrome	0.0352	0.0875	CiPCiCtD
Tiagabine—Decreased Central Nervous System Disorganized Electrical Activity—Lacosamide—epilepsy syndrome	0.0352	0.0875	CiPCiCtD
Tiagabine—Decreased Central Nervous System Disorganized Electrical Activity—Oxcarbazepine—epilepsy syndrome	0.0352	0.0875	CiPCiCtD
Tiagabine—Decreased Central Nervous System Disorganized Electrical Activity—Lamotrigine—epilepsy syndrome	0.0352	0.0875	CiPCiCtD
Tiagabine—Decreased Central Nervous System Disorganized Electrical Activity—Trimethadione—epilepsy syndrome	0.0352	0.0875	CiPCiCtD
Tiagabine—Decreased Central Nervous System Disorganized Electrical Activity—Primidone—epilepsy syndrome	0.0352	0.0875	CiPCiCtD
Tiagabine—bipolar disorder—Oxcarbazepine—epilepsy syndrome	0.0328	0.187	CpDpCtD
Tiagabine—bipolar disorder—Lamotrigine—epilepsy syndrome	0.0328	0.187	CpDpCtD
Tiagabine—bipolar disorder—Topiramate—epilepsy syndrome	0.0279	0.159	CpDpCtD
Tiagabine—Decreased Central Nervous System Disorganized Electrical Activity—Gabapentin—epilepsy syndrome	0.0267	0.0663	CiPCiCtD
Tiagabine—Decreased Central Nervous System Disorganized Electrical Activity—Valproic Acid—epilepsy syndrome	0.0267	0.0663	CiPCiCtD
Tiagabine—bipolar disorder—Carbamazepine—epilepsy syndrome	0.0249	0.142	CpDpCtD
Tiagabine—bipolar disorder—Valproic Acid—epilepsy syndrome	0.0212	0.121	CpDpCtD
Tiagabine—Decreased Central Nervous System Disorganized Electrical Activity—Zonisamide—epilepsy syndrome	0.0202	0.0503	CiPCiCtD
Tiagabine—bipolar disorder—Clonazepam—epilepsy syndrome	0.0199	0.113	CpDpCtD
Tiagabine—Decreased Central Nervous System Disorganized Electrical Activity—Carbamazepine—epilepsy syndrome	0.0172	0.0427	CiPCiCtD
Tiagabine—bipolar disorder—Gabapentin—epilepsy syndrome	0.016	0.0913	CpDpCtD
Tiagabine—Decreased Central Nervous System Disorganized Electrical Activity—Phenytoin—epilepsy syndrome	0.0153	0.0381	CiPCiCtD
Tiagabine—Decreased Central Nervous System Disorganized Electrical Activity—Topiramate—epilepsy syndrome	0.0146	0.0363	CiPCiCtD
Tiagabine—SLC6A1—cerebellar cortex—epilepsy syndrome	0.00534	0.356	CbGeAlD
Tiagabine—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00225	0.0132	CbGbCtD
Tiagabine—CYP3A4—Trimethadione—epilepsy syndrome	0.00209	0.0123	CbGbCtD
Tiagabine—CYP3A4—Felbamate—epilepsy syndrome	0.00209	0.0123	CbGbCtD
Tiagabine—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00196	0.0115	CbGbCtD
Tiagabine—SLC6A1—ganglion—epilepsy syndrome	0.00193	0.129	CbGeAlD
Tiagabine—CYP3A4—Clonazepam—epilepsy syndrome	0.00178	0.0104	CbGbCtD
Tiagabine—CYP3A4—Clobazam—epilepsy syndrome	0.0017	0.01	CbGbCtD
Tiagabine—SLC6A1—hindbrain—epilepsy syndrome	0.00147	0.0978	CbGeAlD
Tiagabine—CYP3A4—Rufinamide—epilepsy syndrome	0.00145	0.0085	CbGbCtD
Tiagabine—CYP3A4—Carbamazepine—epilepsy syndrome	0.00141	0.00829	CbGbCtD
Tiagabine—CYP3A4—Primidone—epilepsy syndrome	0.00132	0.00774	CbGbCtD
Tiagabine—CYP3A4—Phenytoin—epilepsy syndrome	0.00127	0.00743	CbGbCtD
Tiagabine—CYP3A4—Propofol—epilepsy syndrome	0.00118	0.00693	CbGbCtD
Tiagabine—CYP3A4—Acetazolamide—epilepsy syndrome	0.00113	0.00662	CbGbCtD
Tiagabine—CYP3A4—Phenobarbital—epilepsy syndrome	0.00113	0.00662	CbGbCtD
Tiagabine—CYP3A4—Midazolam—epilepsy syndrome	0.00111	0.00653	CbGbCtD
Tiagabine—CYP3A4—Diazepam—epilepsy syndrome	0.00107	0.00628	CbGbCtD
Tiagabine—CYP3A4—Zonisamide—epilepsy syndrome	0.00104	0.00613	CbGbCtD
Tiagabine—CYP3A4—Valproic Acid—epilepsy syndrome	0.000843	0.00495	CbGbCtD
Tiagabine—SLC6A1—brainstem—epilepsy syndrome	0.000841	0.056	CbGeAlD
Tiagabine—SLC6A1—forebrain—epilepsy syndrome	0.000811	0.0541	CbGeAlD
Tiagabine—CYP3A4—Topiramate—epilepsy syndrome	0.000761	0.00447	CbGbCtD
Tiagabine—SLC6A1—telencephalon—epilepsy syndrome	0.000746	0.0497	CbGeAlD
Tiagabine—SLC6A1—medulla oblongata—epilepsy syndrome	0.000586	0.0391	CbGeAlD
Tiagabine—SLC6A1—midbrain—epilepsy syndrome	0.000536	0.0357	CbGeAlD
Tiagabine—SLC6A1—spinal cord—epilepsy syndrome	0.000523	0.0348	CbGeAlD
Tiagabine—SLC6A1—head—epilepsy syndrome	0.000465	0.031	CbGeAlD
Tiagabine—SLC6A1—nervous system—epilepsy syndrome	0.00044	0.0294	CbGeAlD
Tiagabine—SLC6A1—central nervous system—epilepsy syndrome	0.000424	0.0283	CbGeAlD
Tiagabine—SLC6A1—cerebellum—epilepsy syndrome	0.000414	0.0276	CbGeAlD
Tiagabine—SLC6A1—brain—epilepsy syndrome	0.000337	0.0224	CbGeAlD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—CHRNA2—epilepsy syndrome	0.000179	0.00735	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—KCNAB2—epilepsy syndrome	0.000172	0.00704	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—KCND2—epilepsy syndrome	0.000172	0.00704	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—CACNB4—epilepsy syndrome	0.00017	0.00697	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—CACNA2D2—epilepsy syndrome	0.00017	0.00697	CbGpPWpGaD
Tiagabine—SLC6A1—Monoamine Transport—TSC2—epilepsy syndrome	0.000168	0.00687	CbGpPWpGaD
Tiagabine—SLC6A1—Monoamine Transport—AGT—epilepsy syndrome	0.000167	0.00686	CbGpPWpGaD
Tiagabine—SLC6A1—SLC-mediated transmembrane transport—SLC4A10—epilepsy syndrome	0.000166	0.00682	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—GABRG2—epilepsy syndrome	0.000162	0.00665	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—KCNK3—epilepsy syndrome	0.000157	0.00644	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—KCNK9—epilepsy syndrome	0.000157	0.00644	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—GRIK5—epilepsy syndrome	0.000157	0.00644	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—CACNG3—epilepsy syndrome	0.000157	0.00644	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—CACNG2—epilepsy syndrome	0.000146	0.00599	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—HCN1—epilepsy syndrome	0.000146	0.00599	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—KCNV1—epilepsy syndrome	0.000146	0.00599	CbGpPWpGaD
Tiagabine—SLC6A1—SLC-mediated transmembrane transport—SLC8A2—epilepsy syndrome	0.000138	0.00565	CbGpPWpGaD
Tiagabine—SLC6A1—SLC-mediated transmembrane transport—SLCO1A2—epilepsy syndrome	0.000138	0.00565	CbGpPWpGaD
Tiagabine—SLC6A1—SLC-mediated transmembrane transport—SLC9A6—epilepsy syndrome	0.000138	0.00565	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—CHRNA2—epilepsy syndrome	0.000137	0.00563	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—KCNQ2—epilepsy syndrome	0.000137	0.00563	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—KCNQ3—epilepsy syndrome	0.000137	0.00563	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—TXNRD1—epilepsy syndrome	0.000136	0.00559	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—NSF—epilepsy syndrome	0.000136	0.00557	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—SYN1—epilepsy syndrome	0.000136	0.00557	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—STXBP1—epilepsy syndrome	0.000132	0.00542	CbGpPWpGaD
Tiagabine—SLC6A1—SLC-mediated transmembrane transport—SLC8A3—epilepsy syndrome	0.000131	0.00539	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—CACNB4—epilepsy syndrome	0.00013	0.00534	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—CACNA2D2—epilepsy syndrome	0.00013	0.00534	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—KCNB1—epilepsy syndrome	0.00013	0.00534	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—SLC1A1—epilepsy syndrome	0.000129	0.00528	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—GABRG2—epilepsy syndrome	0.000124	0.00509	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—KCNH1—epilepsy syndrome	0.000124	0.00509	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—ABAT—epilepsy syndrome	0.000123	0.00504	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—GABRA5—epilepsy syndrome	0.000123	0.00504	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—KCNJ10—epilepsy syndrome	0.000123	0.00504	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—CACNA1A—epilepsy syndrome	0.000123	0.00504	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—GRIA4—epilepsy syndrome	0.000123	0.00504	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—ARHGEF9—epilepsy syndrome	0.000118	0.00483	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—SLC17A7—epilepsy syndrome	0.000118	0.00483	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—GABRB3—epilepsy syndrome	0.000118	0.00483	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—GABRA1—epilepsy syndrome	0.000118	0.00483	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—GLUL—epilepsy syndrome	0.000116	0.00474	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—ABCC2—epilepsy syndrome	0.000115	0.00471	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—GRIA2—epilepsy syndrome	0.000113	0.00465	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—SLC1A2—epilepsy syndrome	0.00011	0.00449	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—CHRNA7—epilepsy syndrome	0.00011	0.00449	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—GRIK1—epilepsy syndrome	0.00011	0.00449	CbGpPWpGaD
Tiagabine—SLC6A1—SLC-mediated transmembrane transport—APOD—epilepsy syndrome	0.000107	0.00439	CbGpPWpGaD
Tiagabine—SLC6A1—Monoamine Transport—IL1B—epilepsy syndrome	0.000105	0.00428	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—GABRB2—epilepsy syndrome	0.000105	0.00428	CbGpPWpGaD
Tiagabine—SLC6A1—SLC-mediated transmembrane transport—SLC1A1—epilepsy syndrome	0.000104	0.00428	CbGpPWpGaD
Tiagabine—SLC6A1—SLC-mediated transmembrane transport—SLC12A2—epilepsy syndrome	0.000104	0.00428	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—NSF—epilepsy syndrome	0.000104	0.00427	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—SYN1—epilepsy syndrome	0.000104	0.00427	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—CLCN2—epilepsy syndrome	0.000104	0.00425	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—CLCN6—epilepsy syndrome	0.000104	0.00425	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—GAD2—epilepsy syndrome	0.000103	0.00422	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—STXBP1—epilepsy syndrome	0.000101	0.00415	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—SLC1A1—epilepsy syndrome	9.87e-05	0.00405	CbGpPWpGaD
Tiagabine—CYP3A4—Codeine and Morphine Metabolism—ABCC2—epilepsy syndrome	9.81e-05	0.00402	CbGpPWpGaD
Tiagabine—SLC6A1—SLC-mediated transmembrane transport—SLC17A7—epilepsy syndrome	9.55e-05	0.00391	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—GRIA4—epilepsy syndrome	9.42e-05	0.00386	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—CACNA1A—epilepsy syndrome	9.42e-05	0.00386	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—ABAT—epilepsy syndrome	9.42e-05	0.00386	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—GABRA5—epilepsy syndrome	9.42e-05	0.00386	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—KCNJ10—epilepsy syndrome	9.42e-05	0.00386	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—GRIK2—epilepsy syndrome	9.32e-05	0.00382	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—SLC1A3—epilepsy syndrome	9.32e-05	0.00382	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—SLC35A3—epilepsy syndrome	9.24e-05	0.00379	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—SLC35A2—epilepsy syndrome	9.24e-05	0.00379	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—SLC12A5—epilepsy syndrome	9.24e-05	0.00379	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—ARHGEF9—epilepsy syndrome	9.03e-05	0.0037	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—GABRB3—epilepsy syndrome	9.03e-05	0.0037	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—SLC17A7—epilepsy syndrome	9.03e-05	0.0037	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—GABRA1—epilepsy syndrome	9.03e-05	0.0037	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—GAD1—epilepsy syndrome	8.93e-05	0.00366	CbGpPWpGaD
Tiagabine—SLC6A1—SLC-mediated transmembrane transport—SLC1A2—epilepsy syndrome	8.88e-05	0.00364	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—GLUL—epilepsy syndrome	8.86e-05	0.00363	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—GRIA2—epilepsy syndrome	8.69e-05	0.00356	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—SLC6A4—epilepsy syndrome	8.54e-05	0.0035	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—GABBR1—epilepsy syndrome	8.52e-05	0.00349	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—SLC4A10—epilepsy syndrome	8.45e-05	0.00346	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—SLC1A2—epilepsy syndrome	8.4e-05	0.00344	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—CHRNA7—epilepsy syndrome	8.4e-05	0.00344	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—GRIK1—epilepsy syndrome	8.4e-05	0.00344	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—GRIA1—epilepsy syndrome	8.3e-05	0.0034	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—GRIN2A—epilepsy syndrome	8.3e-05	0.0034	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—GABRB2—epilepsy syndrome	8.01e-05	0.00328	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—GAD2—epilepsy syndrome	7.89e-05	0.00323	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—CHRNB2—epilepsy syndrome	7.86e-05	0.00322	CbGpPWpGaD
Tiagabine—SLC6A1—SLC-mediated transmembrane transport—SLC8A1—epilepsy syndrome	7.82e-05	0.0032	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—SLC2A1—epilepsy syndrome	7.72e-05	0.00316	CbGpPWpGaD
Tiagabine—SLC6A1—Monoamine Transport—TNF—epilepsy syndrome	7.59e-05	0.00311	CbGpPWpGaD
Tiagabine—SLC6A1—SLC-mediated transmembrane transport—SLC1A3—epilepsy syndrome	7.55e-05	0.00309	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—KCNMA1—epilepsy syndrome	7.48e-05	0.00307	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—COX3—epilepsy syndrome	7.39e-05	0.00303	CbGpPWpGaD
Tiagabine—CYP3A4—Codeine and Morphine Metabolism—CYP2D6—epilepsy syndrome	7.29e-05	0.00299	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—HBEGF—epilepsy syndrome	7.26e-05	0.00297	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—CHRNA4—epilepsy syndrome	7.14e-05	0.00293	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—KCNJ11—epilepsy syndrome	7.14e-05	0.00292	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—GRIK2—epilepsy syndrome	7.14e-05	0.00292	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—SLC1A3—epilepsy syndrome	7.14e-05	0.00292	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—SLCO1A2—epilepsy syndrome	7e-05	0.00287	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—SLC8A2—epilepsy syndrome	7e-05	0.00287	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—SLC9A6—epilepsy syndrome	7e-05	0.00287	CbGpPWpGaD
Tiagabine—CYP3A4—nervous system—epilepsy syndrome	6.89e-05	0.0046	CbGeAlD
Tiagabine—SLC6A1—Neuronal System—GAD1—epilepsy syndrome	6.84e-05	0.0028	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—SLC8A3—epilepsy syndrome	6.68e-05	0.00274	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—GABRG2—epilepsy syndrome	6.68e-05	0.00274	CbGpPWpGaD
Tiagabine—CYP3A4—central nervous system—epilepsy syndrome	6.64e-05	0.00442	CbGeAlD
Tiagabine—SLC6A1—Neuronal System—GABBR1—epilepsy syndrome	6.53e-05	0.00267	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—GRIA1—epilepsy syndrome	6.36e-05	0.00261	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—GRIN2A—epilepsy syndrome	6.36e-05	0.00261	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—HMOX1—epilepsy syndrome	6.35e-05	0.0026	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—BCHE—epilepsy syndrome	6.29e-05	0.00258	CbGpPWpGaD
Tiagabine—CYP3A4—Irinotecan Pathway—ABCC2—epilepsy syndrome	6.27e-05	0.00257	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—DLG4—epilepsy syndrome	6.14e-05	0.00252	CbGpPWpGaD
Tiagabine—CYP3A4—Tryptophan metabolism—WARS—epilepsy syndrome	6.08e-05	0.00249	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—CHRNB2—epilepsy syndrome	6.03e-05	0.00247	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—GRIN2B—epilepsy syndrome	6e-05	0.00246	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—PLCB1—epilepsy syndrome	5.94e-05	0.00243	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—CHRNA4—epilepsy syndrome	5.47e-05	0.00224	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—APOD—epilepsy syndrome	5.45e-05	0.00223	CbGpPWpGaD
Tiagabine—CYP3A4—Drug Induction of Bile Acid Pathway—ABCC2—epilepsy syndrome	5.37e-05	0.0022	CbGpPWpGaD
Tiagabine—CYP3A4—Irinotecan Pathway—ABCG2—epilepsy syndrome	5.33e-05	0.00218	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—SLC1A1—epilepsy syndrome	5.31e-05	0.00217	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—SLC12A2—epilepsy syndrome	5.31e-05	0.00217	CbGpPWpGaD
Tiagabine—CYP3A4—Codeine and Morphine Metabolism—ABCB1—epilepsy syndrome	5.21e-05	0.00213	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—GABRA5—epilepsy syndrome	5.06e-05	0.00207	CbGpPWpGaD
Tiagabine—SLC6A1—SLC-mediated transmembrane transport—SLC2A1—epilepsy syndrome	4.87e-05	0.00199	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—ARHGEF9—epilepsy syndrome	4.86e-05	0.00199	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—SLC17A7—epilepsy syndrome	4.86e-05	0.00199	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—GABRB3—epilepsy syndrome	4.86e-05	0.00199	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—GABRA1—epilepsy syndrome	4.86e-05	0.00199	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—BCHE—epilepsy syndrome	4.82e-05	0.00198	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—DLG4—epilepsy syndrome	4.71e-05	0.00193	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—GRIN2B—epilepsy syndrome	4.6e-05	0.00188	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—PLCB1—epilepsy syndrome	4.55e-05	0.00186	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—SLC1A2—epilepsy syndrome	4.51e-05	0.00185	CbGpPWpGaD
Tiagabine—CYP3A4—Irinotecan Pathway—BCHE—epilepsy syndrome	4.42e-05	0.00181	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—GABRB2—epilepsy syndrome	4.31e-05	0.00176	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—AQP1—epilepsy syndrome	4.24e-05	0.00174	CbGpPWpGaD
Tiagabine—CYP3A4—Fatty Acid Omega Oxidation—CYP2D6—epilepsy syndrome	4.19e-05	0.00172	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—TRPV1—epilepsy syndrome	4.13e-05	0.00169	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	3.97e-05	0.00163	CbGpPWpGaD
Tiagabine—SLC6A1—SLC-mediated transmembrane transport—AVP—epilepsy syndrome	3.97e-05	0.00163	CbGpPWpGaD
Tiagabine—CYP3A4—Xenobiotics—CYP2C19—epilepsy syndrome	3.91e-05	0.0016	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	3.84e-05	0.00157	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	3.84e-05	0.00157	CbGpPWpGaD
Tiagabine—CYP3A4—Tamoxifen metabolism—CYP2C19—epilepsy syndrome	3.76e-05	0.00154	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	3.68e-05	0.00151	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—PRKCB—epilepsy syndrome	3.57e-05	0.00146	CbGpPWpGaD
Tiagabine—CYP3A4—Xenobiotics—CYP2D6—epilepsy syndrome	3.5e-05	0.00144	CbGpPWpGaD
Tiagabine—CYP3A4—Tamoxifen metabolism—CYP2D6—epilepsy syndrome	3.37e-05	0.00138	CbGpPWpGaD
Tiagabine—CYP3A4—Constitutive Androstane Receptor Pathway—ABCC2—epilepsy syndrome	3.24e-05	0.00133	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	3.13e-05	0.00128	CbGpPWpGaD
Tiagabine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—epilepsy syndrome	3.08e-05	0.00126	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	3.05e-05	0.00125	CbGpPWpGaD
Tiagabine—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—epilepsy syndrome	2.85e-05	0.00117	CbGpPWpGaD
Tiagabine—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—epilepsy syndrome	2.84e-05	0.00116	CbGpPWpGaD
Tiagabine—CYP3A4—Tryptophan metabolism—UBE3A—epilepsy syndrome	2.83e-05	0.00116	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—PRKCB—epilepsy syndrome	2.74e-05	0.00112	CbGpPWpGaD
Tiagabine—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C19—epilepsy syndrome	2.68e-05	0.0011	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	2.59e-05	0.00106	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	2.47e-05	0.00101	CbGpPWpGaD
Tiagabine—SLC6A1—SLC-mediated transmembrane transport—ALB—epilepsy syndrome	2.4e-05	0.000985	CbGpPWpGaD
Tiagabine—CYP3A4—Metapathway biotransformation—KCNAB2—epilepsy syndrome	2.09e-05	0.000855	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	2.03e-05	0.000833	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	2.02e-05	0.000826	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	1.95e-05	0.0008	CbGpPWpGaD
Tiagabine—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—epilepsy syndrome	1.72e-05	0.000704	CbGpPWpGaD
Tiagabine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—epilepsy syndrome	1.64e-05	0.00067	CbGpPWpGaD
Tiagabine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—epilepsy syndrome	1.63e-05	0.000669	CbGpPWpGaD
Tiagabine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C19—epilepsy syndrome	1.62e-05	0.000664	CbGpPWpGaD
Tiagabine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—epilepsy syndrome	1.61e-05	0.00066	CbGpPWpGaD
Tiagabine—CYP3A4—Oxidation by Cytochrome P450—CYP2C19—epilepsy syndrome	1.6e-05	0.000656	CbGpPWpGaD
Tiagabine—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—epilepsy syndrome	1.59e-05	0.000652	CbGpPWpGaD
Tiagabine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—epilepsy syndrome	1.45e-05	0.000596	CbGpPWpGaD
Tiagabine—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—epilepsy syndrome	1.44e-05	0.000588	CbGpPWpGaD
Tiagabine—CYP3A4—Tryptophan metabolism—CAT—epilepsy syndrome	1.32e-05	0.000541	CbGpPWpGaD
Tiagabine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C19—epilepsy syndrome	1.31e-05	0.000539	CbGpPWpGaD
Tiagabine—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—epilepsy syndrome	1.31e-05	0.000535	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	1.22e-05	0.0005	CbGpPWpGaD
Tiagabine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—epilepsy syndrome	1.18e-05	0.000483	CbGpPWpGaD
Tiagabine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—epilepsy syndrome	7.13e-06	0.000292	CbGpPWpGaD
Tiagabine—CYP3A4—Biological oxidations—CYP2C19—epilepsy syndrome	6.98e-06	0.000286	CbGpPWpGaD
Tiagabine—CYP3A4—Biological oxidations—CYP11A1—epilepsy syndrome	6.94e-06	0.000284	CbGpPWpGaD
Tiagabine—CYP3A4—Metapathway biotransformation—CYP2C19—epilepsy syndrome	6.89e-06	0.000282	CbGpPWpGaD
Tiagabine—CYP3A4—Metapathway biotransformation—CYP11A1—epilepsy syndrome	6.84e-06	0.00028	CbGpPWpGaD
Tiagabine—Oedema peripheral—Topiramate—epilepsy syndrome	6.69e-06	0.00011	CcSEcCtD
Tiagabine—Hyperhidrosis—Valproic Acid—epilepsy syndrome	6.69e-06	0.00011	CcSEcCtD
Tiagabine—Cough—Pregabalin—epilepsy syndrome	6.69e-06	0.00011	CcSEcCtD
Tiagabine—Pruritus—Phenytoin—epilepsy syndrome	6.68e-06	0.00011	CcSEcCtD
Tiagabine—Nausea—Levetiracetam—epilepsy syndrome	6.68e-06	0.00011	CcSEcCtD
Tiagabine—Rash—Vigabatrin—epilepsy syndrome	6.67e-06	0.00011	CcSEcCtD
Tiagabine—Dizziness—Felbamate—epilepsy syndrome	6.66e-06	0.00011	CcSEcCtD
Tiagabine—Dermatitis—Vigabatrin—epilepsy syndrome	6.66e-06	0.00011	CcSEcCtD
Tiagabine—Pruritus—Oxcarbazepine—epilepsy syndrome	6.65e-06	0.00011	CcSEcCtD
Tiagabine—Hypersensitivity—Carbamazepine—epilepsy syndrome	6.64e-06	0.00011	CcSEcCtD
Tiagabine—Headache—Vigabatrin—epilepsy syndrome	6.63e-06	0.000109	CcSEcCtD
Tiagabine—Hypertension—Pregabalin—epilepsy syndrome	6.62e-06	0.000109	CcSEcCtD
Tiagabine—Vomiting—Diazepam—epilepsy syndrome	6.62e-06	0.000109	CcSEcCtD
Tiagabine—Anorexia—Valproic Acid—epilepsy syndrome	6.6e-06	0.000109	CcSEcCtD
Tiagabine—Tremor—Gabapentin—epilepsy syndrome	6.59e-06	0.000109	CcSEcCtD
Tiagabine—Rash—Diazepam—epilepsy syndrome	6.56e-06	0.000108	CcSEcCtD
Tiagabine—Dermatitis—Diazepam—epilepsy syndrome	6.56e-06	0.000108	CcSEcCtD
Tiagabine—Visual impairment—Topiramate—epilepsy syndrome	6.55e-06	0.000108	CcSEcCtD
Tiagabine—Arthralgia—Pregabalin—epilepsy syndrome	6.53e-06	0.000108	CcSEcCtD
Tiagabine—Chest pain—Pregabalin—epilepsy syndrome	6.53e-06	0.000108	CcSEcCtD
Tiagabine—Myalgia—Pregabalin—epilepsy syndrome	6.53e-06	0.000108	CcSEcCtD
Tiagabine—Ill-defined disorder—Gabapentin—epilepsy syndrome	6.52e-06	0.000108	CcSEcCtD
Tiagabine—Dizziness—Zonisamide—epilepsy syndrome	6.52e-06	0.000108	CcSEcCtD
Tiagabine—Headache—Diazepam—epilepsy syndrome	6.52e-06	0.000108	CcSEcCtD
Tiagabine—Anxiety—Pregabalin—epilepsy syndrome	6.51e-06	0.000107	CcSEcCtD
Tiagabine—Diarrhoea—Clonazepam—epilepsy syndrome	6.5e-06	0.000107	CcSEcCtD
Tiagabine—Anaemia—Gabapentin—epilepsy syndrome	6.5e-06	0.000107	CcSEcCtD
Tiagabine—Hypotension—Valproic Acid—epilepsy syndrome	6.47e-06	0.000107	CcSEcCtD
Tiagabine—Asthenia—Carbamazepine—epilepsy syndrome	6.47e-06	0.000107	CcSEcCtD
Tiagabine—Agitation—Gabapentin—epilepsy syndrome	6.46e-06	0.000107	CcSEcCtD
Tiagabine—Diarrhoea—Phenytoin—epilepsy syndrome	6.46e-06	0.000107	CcSEcCtD
Tiagabine—Discomfort—Pregabalin—epilepsy syndrome	6.45e-06	0.000106	CcSEcCtD
Tiagabine—Nausea—Fosphenytoin—epilepsy syndrome	6.44e-06	0.000106	CcSEcCtD
Tiagabine—Diarrhoea—Oxcarbazepine—epilepsy syndrome	6.43e-06	0.000106	CcSEcCtD
Tiagabine—Hypersensitivity—Lamotrigine—epilepsy syndrome	6.42e-06	0.000106	CcSEcCtD
Tiagabine—Vomiting—Felbamate—epilepsy syndrome	6.41e-06	0.000106	CcSEcCtD
Tiagabine—Dry mouth—Pregabalin—epilepsy syndrome	6.38e-06	0.000105	CcSEcCtD
Tiagabine—Pruritus—Carbamazepine—epilepsy syndrome	6.38e-06	0.000105	CcSEcCtD
Tiagabine—Rash—Felbamate—epilepsy syndrome	6.35e-06	0.000105	CcSEcCtD
Tiagabine—Dermatitis—Felbamate—epilepsy syndrome	6.35e-06	0.000105	CcSEcCtD
Tiagabine—Malaise—Gabapentin—epilepsy syndrome	6.34e-06	0.000105	CcSEcCtD
Tiagabine—Tinnitus—Topiramate—epilepsy syndrome	6.34e-06	0.000104	CcSEcCtD
Tiagabine—Vertigo—Gabapentin—epilepsy syndrome	6.32e-06	0.000104	CcSEcCtD
Tiagabine—Headache—Felbamate—epilepsy syndrome	6.31e-06	0.000104	CcSEcCtD
Tiagabine—Confusional state—Pregabalin—epilepsy syndrome	6.31e-06	0.000104	CcSEcCtD
Tiagabine—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	6.31e-06	0.000104	CcSEcCtD
Tiagabine—Syncope—Gabapentin—epilepsy syndrome	6.31e-06	0.000104	CcSEcCtD
Tiagabine—Leukopenia—Gabapentin—epilepsy syndrome	6.29e-06	0.000104	CcSEcCtD
Tiagabine—Dizziness—Clonazepam—epilepsy syndrome	6.29e-06	0.000104	CcSEcCtD
Tiagabine—Nausea—Vigabatrin—epilepsy syndrome	6.28e-06	0.000104	CcSEcCtD
Tiagabine—Vomiting—Zonisamide—epilepsy syndrome	6.27e-06	0.000103	CcSEcCtD
Tiagabine—CYP3A4—Biological oxidations—CYP2D6—epilepsy syndrome	6.26e-06	0.000257	CbGpPWpGaD
Tiagabine—Insomnia—Valproic Acid—epilepsy syndrome	6.26e-06	0.000103	CcSEcCtD
Tiagabine—Oedema—Pregabalin—epilepsy syndrome	6.26e-06	0.000103	CcSEcCtD
Tiagabine—Asthenia—Lamotrigine—epilepsy syndrome	6.25e-06	0.000103	CcSEcCtD
Tiagabine—Dizziness—Phenytoin—epilepsy syndrome	6.24e-06	0.000103	CcSEcCtD
Tiagabine—Rash—Zonisamide—epilepsy syndrome	6.22e-06	0.000103	CcSEcCtD
Tiagabine—Infection—Pregabalin—epilepsy syndrome	6.22e-06	0.000103	CcSEcCtD
Tiagabine—Paraesthesia—Valproic Acid—epilepsy syndrome	6.22e-06	0.000103	CcSEcCtD
Tiagabine—Palpitations—Gabapentin—epilepsy syndrome	6.21e-06	0.000102	CcSEcCtD
Tiagabine—Dermatitis—Zonisamide—epilepsy syndrome	6.21e-06	0.000102	CcSEcCtD
Tiagabine—Dizziness—Oxcarbazepine—epilepsy syndrome	6.21e-06	0.000102	CcSEcCtD
Tiagabine—Nausea—Diazepam—epilepsy syndrome	6.18e-06	0.000102	CcSEcCtD
Tiagabine—Loss of consciousness—Gabapentin—epilepsy syndrome	6.18e-06	0.000102	CcSEcCtD
Tiagabine—Headache—Zonisamide—epilepsy syndrome	6.18e-06	0.000102	CcSEcCtD
Tiagabine—CYP3A4—Metapathway biotransformation—CYP2D6—epilepsy syndrome	6.18e-06	0.000253	CbGpPWpGaD
Tiagabine—Dyspnoea—Valproic Acid—epilepsy syndrome	6.17e-06	0.000102	CcSEcCtD
Tiagabine—Diarrhoea—Carbamazepine—epilepsy syndrome	6.17e-06	0.000102	CcSEcCtD
Tiagabine—Pruritus—Lamotrigine—epilepsy syndrome	6.16e-06	0.000102	CcSEcCtD
Tiagabine—Shock—Pregabalin—epilepsy syndrome	6.16e-06	0.000102	CcSEcCtD
Tiagabine—Somnolence—Valproic Acid—epilepsy syndrome	6.15e-06	0.000101	CcSEcCtD
Tiagabine—Cough—Gabapentin—epilepsy syndrome	6.14e-06	0.000101	CcSEcCtD
Tiagabine—Thrombocytopenia—Pregabalin—epilepsy syndrome	6.13e-06	0.000101	CcSEcCtD
Tiagabine—Tachycardia—Pregabalin—epilepsy syndrome	6.11e-06	0.000101	CcSEcCtD
Tiagabine—Chills—Topiramate—epilepsy syndrome	6.1e-06	0.000101	CcSEcCtD
Tiagabine—Dyspepsia—Valproic Acid—epilepsy syndrome	6.09e-06	0.0001	CcSEcCtD
Tiagabine—Hypertension—Gabapentin—epilepsy syndrome	6.07e-06	0.0001	CcSEcCtD
Tiagabine—Hyperhidrosis—Pregabalin—epilepsy syndrome	6.05e-06	9.98e-05	CcSEcCtD
Tiagabine—Vomiting—Clonazepam—epilepsy syndrome	6.04e-06	9.97e-05	CcSEcCtD
Tiagabine—Decreased appetite—Valproic Acid—epilepsy syndrome	6.02e-06	9.92e-05	CcSEcCtD
Tiagabine—Alopecia—Topiramate—epilepsy syndrome	6.01e-06	9.9e-05	CcSEcCtD
Tiagabine—Vomiting—Phenytoin—epilepsy syndrome	6e-06	9.9e-05	CcSEcCtD
Tiagabine—Rash—Clonazepam—epilepsy syndrome	5.99e-06	9.88e-05	CcSEcCtD
Tiagabine—Dermatitis—Clonazepam—epilepsy syndrome	5.99e-06	9.88e-05	CcSEcCtD
Tiagabine—Chest pain—Gabapentin—epilepsy syndrome	5.99e-06	9.87e-05	CcSEcCtD
Tiagabine—Myalgia—Gabapentin—epilepsy syndrome	5.99e-06	9.87e-05	CcSEcCtD
Tiagabine—Arthralgia—Gabapentin—epilepsy syndrome	5.99e-06	9.87e-05	CcSEcCtD
Tiagabine—Nausea—Felbamate—epilepsy syndrome	5.99e-06	9.87e-05	CcSEcCtD
Tiagabine—Vomiting—Oxcarbazepine—epilepsy syndrome	5.97e-06	9.85e-05	CcSEcCtD
Tiagabine—Fatigue—Valproic Acid—epilepsy syndrome	5.97e-06	9.84e-05	CcSEcCtD
Tiagabine—Anxiety—Gabapentin—epilepsy syndrome	5.97e-06	9.84e-05	CcSEcCtD
Tiagabine—Anorexia—Pregabalin—epilepsy syndrome	5.97e-06	9.84e-05	CcSEcCtD
Tiagabine—Dizziness—Carbamazepine—epilepsy syndrome	5.96e-06	9.83e-05	CcSEcCtD
Tiagabine—Diarrhoea—Lamotrigine—epilepsy syndrome	5.96e-06	9.83e-05	CcSEcCtD
Tiagabine—Headache—Clonazepam—epilepsy syndrome	5.96e-06	9.82e-05	CcSEcCtD
Tiagabine—Rash—Phenytoin—epilepsy syndrome	5.95e-06	9.82e-05	CcSEcCtD
Tiagabine—Dermatitis—Phenytoin—epilepsy syndrome	5.95e-06	9.81e-05	CcSEcCtD
Tiagabine—Rash—Oxcarbazepine—epilepsy syndrome	5.92e-06	9.77e-05	CcSEcCtD
Tiagabine—Pain—Valproic Acid—epilepsy syndrome	5.92e-06	9.76e-05	CcSEcCtD
Tiagabine—Constipation—Valproic Acid—epilepsy syndrome	5.92e-06	9.76e-05	CcSEcCtD
Tiagabine—Dermatitis—Oxcarbazepine—epilepsy syndrome	5.92e-06	9.76e-05	CcSEcCtD
Tiagabine—Headache—Phenytoin—epilepsy syndrome	5.92e-06	9.76e-05	CcSEcCtD
Tiagabine—Discomfort—Gabapentin—epilepsy syndrome	5.91e-06	9.75e-05	CcSEcCtD
Tiagabine—Headache—Oxcarbazepine—epilepsy syndrome	5.88e-06	9.7e-05	CcSEcCtD
Tiagabine—Nausea—Zonisamide—epilepsy syndrome	5.86e-06	9.66e-05	CcSEcCtD
Tiagabine—Dry mouth—Gabapentin—epilepsy syndrome	5.85e-06	9.65e-05	CcSEcCtD
Tiagabine—Hypotension—Pregabalin—epilepsy syndrome	5.85e-06	9.64e-05	CcSEcCtD
Tiagabine—Flatulence—Topiramate—epilepsy syndrome	5.83e-06	9.61e-05	CcSEcCtD
Tiagabine—Tension—Topiramate—epilepsy syndrome	5.81e-06	9.57e-05	CcSEcCtD
Tiagabine—Dysgeusia—Topiramate—epilepsy syndrome	5.79e-06	9.55e-05	CcSEcCtD
Tiagabine—Confusional state—Gabapentin—epilepsy syndrome	5.79e-06	9.54e-05	CcSEcCtD
Tiagabine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	5.78e-06	0.000237	CbGpPWpGaD
Tiagabine—Dizziness—Lamotrigine—epilepsy syndrome	5.76e-06	9.5e-05	CcSEcCtD
Tiagabine—Nervousness—Topiramate—epilepsy syndrome	5.75e-06	9.48e-05	CcSEcCtD
Tiagabine—Oedema—Gabapentin—epilepsy syndrome	5.74e-06	9.46e-05	CcSEcCtD
Tiagabine—Vomiting—Carbamazepine—epilepsy syndrome	5.73e-06	9.45e-05	CcSEcCtD
Tiagabine—Back pain—Topiramate—epilepsy syndrome	5.72e-06	9.44e-05	CcSEcCtD
Tiagabine—Feeling abnormal—Valproic Acid—epilepsy syndrome	5.7e-06	9.41e-05	CcSEcCtD
Tiagabine—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	5.7e-06	9.4e-05	CcSEcCtD
Tiagabine—Infection—Gabapentin—epilepsy syndrome	5.7e-06	9.4e-05	CcSEcCtD
Tiagabine—Muscle spasms—Topiramate—epilepsy syndrome	5.69e-06	9.38e-05	CcSEcCtD
Tiagabine—Rash—Carbamazepine—epilepsy syndrome	5.68e-06	9.37e-05	CcSEcCtD
Tiagabine—Dermatitis—Carbamazepine—epilepsy syndrome	5.68e-06	9.36e-05	CcSEcCtD
Tiagabine—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	5.66e-06	9.33e-05	CcSEcCtD
Tiagabine—Insomnia—Pregabalin—epilepsy syndrome	5.66e-06	9.33e-05	CcSEcCtD
Tiagabine—Nausea—Clonazepam—epilepsy syndrome	5.65e-06	9.31e-05	CcSEcCtD
Tiagabine—Headache—Carbamazepine—epilepsy syndrome	5.65e-06	9.31e-05	CcSEcCtD
Tiagabine—Shock—Gabapentin—epilepsy syndrome	5.65e-06	9.31e-05	CcSEcCtD
Tiagabine—Paraesthesia—Pregabalin—epilepsy syndrome	5.62e-06	9.27e-05	CcSEcCtD
Tiagabine—Thrombocytopenia—Gabapentin—epilepsy syndrome	5.62e-06	9.27e-05	CcSEcCtD
Tiagabine—Nausea—Phenytoin—epilepsy syndrome	5.61e-06	9.25e-05	CcSEcCtD
Tiagabine—Tachycardia—Gabapentin—epilepsy syndrome	5.6e-06	9.24e-05	CcSEcCtD
Tiagabine—Dyspnoea—Pregabalin—epilepsy syndrome	5.58e-06	9.2e-05	CcSEcCtD
Tiagabine—Nausea—Oxcarbazepine—epilepsy syndrome	5.58e-06	9.2e-05	CcSEcCtD
Tiagabine—Somnolence—Pregabalin—epilepsy syndrome	5.56e-06	9.17e-05	CcSEcCtD
Tiagabine—Hyperhidrosis—Gabapentin—epilepsy syndrome	5.55e-06	9.15e-05	CcSEcCtD
Tiagabine—Tremor—Topiramate—epilepsy syndrome	5.54e-06	9.14e-05	CcSEcCtD
Tiagabine—Vomiting—Lamotrigine—epilepsy syndrome	5.54e-06	9.13e-05	CcSEcCtD
Tiagabine—Urticaria—Valproic Acid—epilepsy syndrome	5.5e-06	9.07e-05	CcSEcCtD
Tiagabine—Rash—Lamotrigine—epilepsy syndrome	5.49e-06	9.06e-05	CcSEcCtD
Tiagabine—Ill-defined disorder—Topiramate—epilepsy syndrome	5.49e-06	9.05e-05	CcSEcCtD
Tiagabine—Dermatitis—Lamotrigine—epilepsy syndrome	5.49e-06	9.05e-05	CcSEcCtD
Tiagabine—Body temperature increased—Valproic Acid—epilepsy syndrome	5.47e-06	9.02e-05	CcSEcCtD
Tiagabine—Abdominal pain—Valproic Acid—epilepsy syndrome	5.47e-06	9.02e-05	CcSEcCtD
Tiagabine—Anorexia—Gabapentin—epilepsy syndrome	5.47e-06	9.02e-05	CcSEcCtD
Tiagabine—Anaemia—Topiramate—epilepsy syndrome	5.47e-06	9.02e-05	CcSEcCtD
Tiagabine—Headache—Lamotrigine—epilepsy syndrome	5.46e-06	9e-05	CcSEcCtD
Tiagabine—Decreased appetite—Pregabalin—epilepsy syndrome	5.44e-06	8.97e-05	CcSEcCtD
Tiagabine—Agitation—Topiramate—epilepsy syndrome	5.44e-06	8.97e-05	CcSEcCtD
Tiagabine—Fatigue—Pregabalin—epilepsy syndrome	5.4e-06	8.9e-05	CcSEcCtD
Tiagabine—Hypotension—Gabapentin—epilepsy syndrome	5.36e-06	8.84e-05	CcSEcCtD
Tiagabine—Nausea—Carbamazepine—epilepsy syndrome	5.35e-06	8.83e-05	CcSEcCtD
Tiagabine—Constipation—Pregabalin—epilepsy syndrome	5.35e-06	8.83e-05	CcSEcCtD
Tiagabine—Pain—Pregabalin—epilepsy syndrome	5.35e-06	8.83e-05	CcSEcCtD
Tiagabine—Malaise—Topiramate—epilepsy syndrome	5.33e-06	8.8e-05	CcSEcCtD
Tiagabine—Vertigo—Topiramate—epilepsy syndrome	5.31e-06	8.76e-05	CcSEcCtD
Tiagabine—Syncope—Topiramate—epilepsy syndrome	5.31e-06	8.75e-05	CcSEcCtD
Tiagabine—Leukopenia—Topiramate—epilepsy syndrome	5.3e-06	8.73e-05	CcSEcCtD
Tiagabine—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	5.23e-06	8.62e-05	CcSEcCtD
Tiagabine—Palpitations—Topiramate—epilepsy syndrome	5.23e-06	8.62e-05	CcSEcCtD
Tiagabine—Loss of consciousness—Topiramate—epilepsy syndrome	5.2e-06	8.57e-05	CcSEcCtD
Tiagabine—Insomnia—Gabapentin—epilepsy syndrome	5.19e-06	8.56e-05	CcSEcCtD
Tiagabine—Nausea—Lamotrigine—epilepsy syndrome	5.17e-06	8.53e-05	CcSEcCtD
Tiagabine—Cough—Topiramate—epilepsy syndrome	5.16e-06	8.51e-05	CcSEcCtD
Tiagabine—Feeling abnormal—Pregabalin—epilepsy syndrome	5.16e-06	8.5e-05	CcSEcCtD
Tiagabine—Paraesthesia—Gabapentin—epilepsy syndrome	5.15e-06	8.5e-05	CcSEcCtD
Tiagabine—Gastrointestinal pain—Pregabalin—epilepsy syndrome	5.12e-06	8.44e-05	CcSEcCtD
Tiagabine—Dyspnoea—Gabapentin—epilepsy syndrome	5.12e-06	8.44e-05	CcSEcCtD
Tiagabine—Hypertension—Topiramate—epilepsy syndrome	5.11e-06	8.42e-05	CcSEcCtD
Tiagabine—Somnolence—Gabapentin—epilepsy syndrome	5.1e-06	8.41e-05	CcSEcCtD
Tiagabine—Hypersensitivity—Valproic Acid—epilepsy syndrome	5.1e-06	8.41e-05	CcSEcCtD
Tiagabine—Dyspepsia—Gabapentin—epilepsy syndrome	5.05e-06	8.33e-05	CcSEcCtD
Tiagabine—Chest pain—Topiramate—epilepsy syndrome	5.04e-06	8.31e-05	CcSEcCtD
Tiagabine—Myalgia—Topiramate—epilepsy syndrome	5.04e-06	8.31e-05	CcSEcCtD
Tiagabine—Arthralgia—Topiramate—epilepsy syndrome	5.04e-06	8.31e-05	CcSEcCtD
Tiagabine—Anxiety—Topiramate—epilepsy syndrome	5.02e-06	8.28e-05	CcSEcCtD
Tiagabine—Decreased appetite—Gabapentin—epilepsy syndrome	4.99e-06	8.23e-05	CcSEcCtD
Tiagabine—Discomfort—Topiramate—epilepsy syndrome	4.98e-06	8.21e-05	CcSEcCtD
Tiagabine—Urticaria—Pregabalin—epilepsy syndrome	4.97e-06	8.2e-05	CcSEcCtD
Tiagabine—Asthenia—Valproic Acid—epilepsy syndrome	4.97e-06	8.19e-05	CcSEcCtD
Tiagabine—Fatigue—Gabapentin—epilepsy syndrome	4.95e-06	8.16e-05	CcSEcCtD
Tiagabine—Abdominal pain—Pregabalin—epilepsy syndrome	4.95e-06	8.16e-05	CcSEcCtD
Tiagabine—Body temperature increased—Pregabalin—epilepsy syndrome	4.95e-06	8.16e-05	CcSEcCtD
Tiagabine—Dry mouth—Topiramate—epilepsy syndrome	4.93e-06	8.12e-05	CcSEcCtD
Tiagabine—Constipation—Gabapentin—epilepsy syndrome	4.91e-06	8.09e-05	CcSEcCtD
Tiagabine—Pain—Gabapentin—epilepsy syndrome	4.91e-06	8.09e-05	CcSEcCtD
Tiagabine—Pruritus—Valproic Acid—epilepsy syndrome	4.9e-06	8.08e-05	CcSEcCtD
Tiagabine—Confusional state—Topiramate—epilepsy syndrome	4.87e-06	8.03e-05	CcSEcCtD
Tiagabine—Oedema—Topiramate—epilepsy syndrome	4.83e-06	7.96e-05	CcSEcCtD
Tiagabine—Infection—Topiramate—epilepsy syndrome	4.8e-06	7.91e-05	CcSEcCtD
Tiagabine—CYP3A4—Metabolism—CA13—epilepsy syndrome	4.78e-06	0.000196	CbGpPWpGaD
Tiagabine—Shock—Topiramate—epilepsy syndrome	4.75e-06	7.83e-05	CcSEcCtD
Tiagabine—Diarrhoea—Valproic Acid—epilepsy syndrome	4.74e-06	7.81e-05	CcSEcCtD
Tiagabine—Feeling abnormal—Gabapentin—epilepsy syndrome	4.73e-06	7.8e-05	CcSEcCtD
Tiagabine—Thrombocytopenia—Topiramate—epilepsy syndrome	4.73e-06	7.8e-05	CcSEcCtD
Tiagabine—Tachycardia—Topiramate—epilepsy syndrome	4.71e-06	7.77e-05	CcSEcCtD
Tiagabine—Gastrointestinal pain—Gabapentin—epilepsy syndrome	4.69e-06	7.74e-05	CcSEcCtD
Tiagabine—Hyperhidrosis—Topiramate—epilepsy syndrome	4.67e-06	7.7e-05	CcSEcCtD
Tiagabine—Hypersensitivity—Pregabalin—epilepsy syndrome	4.61e-06	7.6e-05	CcSEcCtD
Tiagabine—Anorexia—Topiramate—epilepsy syndrome	4.6e-06	7.59e-05	CcSEcCtD
Tiagabine—Dizziness—Valproic Acid—epilepsy syndrome	4.58e-06	7.55e-05	CcSEcCtD
Tiagabine—Urticaria—Gabapentin—epilepsy syndrome	4.56e-06	7.52e-05	CcSEcCtD
Tiagabine—Body temperature increased—Gabapentin—epilepsy syndrome	4.54e-06	7.48e-05	CcSEcCtD
Tiagabine—Abdominal pain—Gabapentin—epilepsy syndrome	4.54e-06	7.48e-05	CcSEcCtD
Tiagabine—Hypotension—Topiramate—epilepsy syndrome	4.51e-06	7.44e-05	CcSEcCtD
Tiagabine—Asthenia—Pregabalin—epilepsy syndrome	4.49e-06	7.4e-05	CcSEcCtD
Tiagabine—Pruritus—Pregabalin—epilepsy syndrome	4.43e-06	7.3e-05	CcSEcCtD
Tiagabine—Vomiting—Valproic Acid—epilepsy syndrome	4.4e-06	7.26e-05	CcSEcCtD
Tiagabine—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	4.4e-06	7.25e-05	CcSEcCtD
Tiagabine—Insomnia—Topiramate—epilepsy syndrome	4.37e-06	7.2e-05	CcSEcCtD
Tiagabine—Rash—Valproic Acid—epilepsy syndrome	4.36e-06	7.2e-05	CcSEcCtD
Tiagabine—Dermatitis—Valproic Acid—epilepsy syndrome	4.36e-06	7.19e-05	CcSEcCtD
Tiagabine—Headache—Valproic Acid—epilepsy syndrome	4.34e-06	7.15e-05	CcSEcCtD
Tiagabine—Paraesthesia—Topiramate—epilepsy syndrome	4.34e-06	7.15e-05	CcSEcCtD
Tiagabine—Dyspnoea—Topiramate—epilepsy syndrome	4.3e-06	7.1e-05	CcSEcCtD
Tiagabine—Somnolence—Topiramate—epilepsy syndrome	4.29e-06	7.08e-05	CcSEcCtD
Tiagabine—Diarrhoea—Pregabalin—epilepsy syndrome	4.28e-06	7.06e-05	CcSEcCtD
Tiagabine—Dyspepsia—Topiramate—epilepsy syndrome	4.25e-06	7.01e-05	CcSEcCtD
Tiagabine—Hypersensitivity—Gabapentin—epilepsy syndrome	4.23e-06	6.97e-05	CcSEcCtD
Tiagabine—Decreased appetite—Topiramate—epilepsy syndrome	4.2e-06	6.92e-05	CcSEcCtD
Tiagabine—Fatigue—Topiramate—epilepsy syndrome	4.16e-06	6.86e-05	CcSEcCtD
Tiagabine—Dizziness—Pregabalin—epilepsy syndrome	4.14e-06	6.82e-05	CcSEcCtD
Tiagabine—Constipation—Topiramate—epilepsy syndrome	4.13e-06	6.81e-05	CcSEcCtD
Tiagabine—Pain—Topiramate—epilepsy syndrome	4.13e-06	6.81e-05	CcSEcCtD
Tiagabine—Asthenia—Gabapentin—epilepsy syndrome	4.12e-06	6.79e-05	CcSEcCtD
Tiagabine—Nausea—Valproic Acid—epilepsy syndrome	4.11e-06	6.78e-05	CcSEcCtD
Tiagabine—Pruritus—Gabapentin—epilepsy syndrome	4.06e-06	6.7e-05	CcSEcCtD
Tiagabine—Vomiting—Pregabalin—epilepsy syndrome	3.98e-06	6.56e-05	CcSEcCtD
Tiagabine—Feeling abnormal—Topiramate—epilepsy syndrome	3.98e-06	6.56e-05	CcSEcCtD
Tiagabine—Gastrointestinal pain—Topiramate—epilepsy syndrome	3.95e-06	6.51e-05	CcSEcCtD
Tiagabine—Rash—Pregabalin—epilepsy syndrome	3.95e-06	6.51e-05	CcSEcCtD
Tiagabine—Dermatitis—Pregabalin—epilepsy syndrome	3.94e-06	6.5e-05	CcSEcCtD
Tiagabine—Diarrhoea—Gabapentin—epilepsy syndrome	3.93e-06	6.48e-05	CcSEcCtD
Tiagabine—Headache—Pregabalin—epilepsy syndrome	3.92e-06	6.47e-05	CcSEcCtD
Tiagabine—Urticaria—Topiramate—epilepsy syndrome	3.84e-06	6.33e-05	CcSEcCtD
Tiagabine—Abdominal pain—Topiramate—epilepsy syndrome	3.82e-06	6.29e-05	CcSEcCtD
Tiagabine—Body temperature increased—Topiramate—epilepsy syndrome	3.82e-06	6.29e-05	CcSEcCtD
Tiagabine—Dizziness—Gabapentin—epilepsy syndrome	3.79e-06	6.26e-05	CcSEcCtD
Tiagabine—Nausea—Pregabalin—epilepsy syndrome	3.72e-06	6.13e-05	CcSEcCtD
Tiagabine—Vomiting—Gabapentin—epilepsy syndrome	3.65e-06	6.02e-05	CcSEcCtD
Tiagabine—CYP3A4—Metabolism—GLUD1—epilepsy syndrome	3.62e-06	0.000148	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—ADK—epilepsy syndrome	3.62e-06	0.000148	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—L2HGDH—epilepsy syndrome	3.62e-06	0.000148	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—CERS1—epilepsy syndrome	3.62e-06	0.000148	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PDXK—epilepsy syndrome	3.62e-06	0.000148	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—FAR1—epilepsy syndrome	3.62e-06	0.000148	CbGpPWpGaD
Tiagabine—Rash—Gabapentin—epilepsy syndrome	3.62e-06	5.97e-05	CcSEcCtD
Tiagabine—Dermatitis—Gabapentin—epilepsy syndrome	3.62e-06	5.96e-05	CcSEcCtD
Tiagabine—Headache—Gabapentin—epilepsy syndrome	3.6e-06	5.93e-05	CcSEcCtD
Tiagabine—Hypersensitivity—Topiramate—epilepsy syndrome	3.56e-06	5.87e-05	CcSEcCtD
Tiagabine—Asthenia—Topiramate—epilepsy syndrome	3.46e-06	5.71e-05	CcSEcCtD
Tiagabine—Pruritus—Topiramate—epilepsy syndrome	3.42e-06	5.63e-05	CcSEcCtD
Tiagabine—Nausea—Gabapentin—epilepsy syndrome	3.41e-06	5.62e-05	CcSEcCtD
Tiagabine—CYP3A4—Metabolism—PNPO—epilepsy syndrome	3.31e-06	0.000136	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	3.31e-06	0.000136	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	3.31e-06	0.000136	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—GAMT—epilepsy syndrome	3.31e-06	0.000136	CbGpPWpGaD
Tiagabine—Diarrhoea—Topiramate—epilepsy syndrome	3.3e-06	5.45e-05	CcSEcCtD
Tiagabine—Dizziness—Topiramate—epilepsy syndrome	3.19e-06	5.27e-05	CcSEcCtD
Tiagabine—CYP3A4—Metabolism—QDPR—epilepsy syndrome	3.08e-06	0.000126	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—CA4—epilepsy syndrome	3.08e-06	0.000126	CbGpPWpGaD
Tiagabine—Vomiting—Topiramate—epilepsy syndrome	3.07e-06	5.06e-05	CcSEcCtD
Tiagabine—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	3.07e-06	0.000126	CbGpPWpGaD
Tiagabine—Rash—Topiramate—epilepsy syndrome	3.04e-06	5.02e-05	CcSEcCtD
Tiagabine—Dermatitis—Topiramate—epilepsy syndrome	3.04e-06	5.02e-05	CcSEcCtD
Tiagabine—Headache—Topiramate—epilepsy syndrome	3.02e-06	4.99e-05	CcSEcCtD
Tiagabine—CYP3A4—Metabolism—COX3—epilepsy syndrome	2.89e-06	0.000119	CbGpPWpGaD
Tiagabine—Nausea—Topiramate—epilepsy syndrome	2.87e-06	4.73e-05	CcSEcCtD
Tiagabine—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	2.74e-06	0.000112	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	2.74e-06	0.000112	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	2.74e-06	0.000112	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PFKL—epilepsy syndrome	2.74e-06	0.000112	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	2.74e-06	0.000112	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—NEU1—epilepsy syndrome	2.51e-06	0.000103	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—UPB1—epilepsy syndrome	2.51e-06	0.000103	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—ATIC—epilepsy syndrome	2.51e-06	0.000103	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	2.42e-06	9.9e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—GBE1—epilepsy syndrome	2.33e-06	9.56e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	2.33e-06	9.56e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	2.19e-06	8.99e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	2.13e-06	8.74e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—NT5E—epilepsy syndrome	2.08e-06	8.52e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—ALAD—epilepsy syndrome	2.08e-06	8.52e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	1.98e-06	8.13e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	1.98e-06	8.13e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	1.94e-06	7.95e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—ADSL—epilepsy syndrome	1.9e-06	7.79e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—GLUL—epilepsy syndrome	1.86e-06	7.64e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	1.83e-06	7.5e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	1.71e-06	7.01e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—AQP1—epilepsy syndrome	1.66e-06	6.81e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	1.5e-06	6.16e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	1.5e-06	6.16e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	1.23e-06	5.02e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	1.19e-06	4.89e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	1.19e-06	4.86e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	1.07e-06	4.39e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	1.02e-06	4.18e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—BCHE—epilepsy syndrome	1.02e-06	4.16e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	9.69e-07	3.97e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	9.58e-07	3.93e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—TH—epilepsy syndrome	9.55e-07	3.91e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	7.97e-07	3.26e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—CAT—epilepsy syndrome	7.86e-07	3.22e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	7.65e-07	3.13e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—GPX1—epilepsy syndrome	7.11e-07	2.91e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—AGT—epilepsy syndrome	6.23e-07	2.55e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—APOE—epilepsy syndrome	6.11e-07	2.5e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—POMC—epilepsy syndrome	5.25e-07	2.15e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—ALB—epilepsy syndrome	4.78e-07	1.96e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	4.19e-07	1.71e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—AKT1—epilepsy syndrome	2.1e-07	8.62e-06	CbGpPWpGaD
